Perceptive Advisors - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 90 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2016. The put-call ratio across all filers is 0.24 and the average weighting 0.5%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2020$61,606,000
+14.7%
664,574
-3.5%
0.90%
+3.3%
Q2 2020$53,713,000
+33.4%
688,6240.0%0.87%
-17.1%
Q1 2020$40,271,000
-18.7%
688,624
+11.3%
1.05%
+6.6%
Q4 2019$49,558,000
-23.6%
618,624
-30.0%
0.98%
-43.7%
Q3 2019$64,893,000
-43.3%
883,264
-27.2%
1.75%
-33.4%
Q2 2019$114,397,000
+12.4%
1,212,731
-4.6%
2.62%
-8.6%
Q1 2019$101,748,000
+134.0%
1,271,054
+48.3%
2.87%
+73.5%
Q4 2018$43,484,000
-40.8%
857,326
-8.9%
1.66%
-15.7%
Q3 2018$73,466,000
+20.4%
941,147
-2.1%
1.96%
+22.8%
Q2 2018$61,014,000
-35.4%
961,147
-6.7%
1.60%
-39.6%
Q1 2018$94,491,000
+9.9%
1,030,434
-9.6%
2.65%
-7.2%
Q4 2017$86,000,000
+45.3%
1,140,434
+34.3%
2.85%
+152.3%
Q3 2017$59,172,000
+162.6%
849,322
+91.0%
1.13%
-0.4%
Q2 2017$22,530,000
+22.0%
444,661
-3.7%
1.13%
+7.8%
Q1 2017$18,461,000
+140.4%
461,642
+68.6%
1.05%
+92.7%
Q4 2016$7,680,000
-43.8%
273,820
-40.5%
0.55%
-38.1%
Q3 2016$13,662,000
+45.3%
460,024
-0.9%
0.88%
+35.3%
Q2 2016$9,404,000
+28.8%
464,404
+14.8%
0.65%
+1.9%
Q1 2016$7,299,000
-31.5%
404,4040.0%0.64%
-18.8%
Q4 2015$10,652,000
-38.3%
404,404
-50.0%
0.79%
+14.2%
Q3 2015$17,258,000
+61.1%
808,808
+100.0%
0.69%
+7.0%
Q2 2015$10,712,000404,4040.64%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2016
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 380,012$42,618,0008.86%
DAFNA Capital Management LLC 206,911$23,205,0006.90%
Casdin Capital, LLC 1,550,000$173,833,0005.15%
Eagle Health Investments LP 62,060$6,960,0004.45%
SIB LLC 54,912$6,158,0004.11%
CADIAN CAPITAL MANAGEMENT, LP 1,059,450$118,817,0003.05%
Tri Locum Partners LP 73,906$8,289,0003.01%
Integral Health Asset Management, LLC 85,000$9,533,0002.84%
MAKENA CAPITAL MANAGEMENT LLC 38,924$4,365,0002.42%
Rock Springs Capital Management LP 842,000$94,430,0002.00%
View complete list of BLUEPRINT MEDICINES CORP shareholders